Inside myeloma: Why it starts, how it survives, and where research is headed
Myeloma doesn’t appear overnight. It develops through a series of changes in the immune system that allow abnormal plasma cells to grow, adapt and evade the body’s defenses. In this Simon Says session, Zainul S. Hasanali, MD, PhD, the Daniel and Lori Efroymson Scholar in Oncology, breaks down what scientists now understand about how myeloma starts, why it persists, and how it interacts with the bone marrow environment. He also discusses the latest research aimed at predicting who is at risk, improving treatment responses, and even intercepting the disease before it becomes cancer. This session offers an expert-guided conversation about the latest science and what it could mean for myeloma patients and their families.
